id	sid	tid	token	lemma	pos
ct-9997	1	1	2018	2018	NUM
ct-9997	1	2	:	:	PUNCT
ct-9997	1	3	enrofloxacin	enrofloxacin	PROPN
ct-9997	1	4	administration	administration	PROPN
ct-9997	1	5	to	to	ADP
ct-9997	1	6	late	late	ADJ
ct-9997	1	7	pregnant	pregnant	ADJ
ct-9997	1	8	mares	mare	NOUN
ct-9997	1	9	does	do	AUX
ct-9997	1	10	not	not	PART
ct-9997	1	11	cause	cause	VERB
ct-9997	1	12	articular	articular	ADJ
ct-9997	1	13	lesions	lesion	NOUN
ct-9997	1	14	or	or	CCONJ
ct-9997	1	15	decrease	decrease	VERB
ct-9997	1	16	tendon	tendon	NOUN
ct-9997	1	17	strength	strength	NOUN
ct-9997	1	18	in	in	ADP
ct-9997	1	19	the	the	DET
ct-9997	1	20	resulting	result	VERB
ct-9997	1	21	foals	foal	NOUN
ct-9997	1	22	enrofloxacin	enrofloxacin	PROPN
ct-9997	1	23	administration	administration	NOUN
ct-9997	1	24	to	to	ADP
ct-9997	1	25	late	late	ADJ
ct-9997	1	26	pregnant	pregnant	ADJ
ct-9997	1	27	mares	mare	NOUN
ct-9997	1	28	does	do	AUX
ct-9997	1	29	not	not	PART
ct-9997	1	30	cause	cause	VERB
ct-9997	1	31	articular	articular	ADJ
ct-9997	1	32	lesions	lesion	NOUN
ct-9997	1	33	or	or	CCONJ
ct-9997	1	34	decrease	decrease	VERB
ct-9997	1	35	tendon	tendon	NOUN
ct-9997	1	36	strength	strength	NOUN
ct-9997	1	37	in	in	ADP
ct-9997	1	38	the	the	DET
ct-9997	1	39	resulting	result	VERB
ct-9997	1	40	foals	foal	NOUN
ct-9997	1	41	r.e	r.e	PROPN
ct-9997	1	42	.	.	PROPN
ct-9997	1	43	ellerbrock	ellerbrock	PROPN
ct-9997	1	44	,	,	PUNCT
ct-9997	1	45	a	a	DET
ct-9997	1	46	i.f	i.f	PROPN
ct-9997	2	1	.	.	PUNCT
ct-9997	2	2	canisso	canisso	PROPN
ct-9997	2	3	,	,	PUNCT
ct-9997	2	4	a	a	DET
ct-9997	2	5	p.j	p.j	PROPN
ct-9997	2	6	.	.	PROPN
ct-9997	2	7	roady	roady	PROPN
ct-9997	2	8	,	,	PUNCT
ct-9997	2	9	a	a	DET
ct-9997	2	10	g.	g.	NOUN
ct-9997	2	11	podico	podico	PROPN
ct-9997	2	12	,	,	PUNCT
ct-9997	2	13	a	a	DET
ct-9997	2	14	b.	b.	PROPN
ct-9997	2	15	curcio	curcio	PROPN
ct-9997	2	16	,	,	PUNCT
ct-9997	2	17	a	a	DET
ct-9997	2	18	f.s	f.s	PROPN
ct-9997	2	19	.	.	PROPN
ct-9997	2	20	lima	lima	PROPN
ct-9997	2	21	,	,	PUNCT
ct-9997	2	22	a	a	DET
ct-9997	2	23	z.	z.	PROPN
ct-9997	2	24	lib	lib	PROPN
ct-9997	2	25	adepartment	adepartment	NOUN
ct-9997	2	26	of	of	ADP
ct-9997	2	27	veterinary	veterinary	ADJ
ct-9997	2	28	clinical	clinical	ADJ
ct-9997	2	29	medicine	medicine	NOUN
ct-9997	2	30	,	,	PUNCT
ct-9997	2	31	broy	broy	PROPN
ct-9997	2	32	carver	carver	PROPN
ct-9997	2	33	biotechnology	biotechnology	NOUN
ct-9997	2	34	center	center	NOUN
ct-9997	2	35	,	,	PUNCT
ct-9997	2	36	university	university	PROPN
ct-9997	2	37	of	of	ADP
ct-9997	2	38	illinois	illinois	PROPN
ct-9997	2	39	urbana	urbana	PROPN
ct-9997	2	40	-	-	PUNCT
ct-9997	2	41	champaign	champaign	PROPN
ct-9997	2	42	,	,	PUNCT
ct-9997	2	43	urbana	urbana	PROPN
ct-9997	2	44	,	,	PUNCT
ct-9997	2	45	il	il	PROPN
ct-9997	2	46	enrofloxacin	enrofloxacin	PROPN
ct-9997	2	47	would	would	AUX
ct-9997	2	48	be	be	AUX
ct-9997	2	49	an	an	DET
ct-9997	2	50	excellent	excellent	ADJ
ct-9997	2	51	antimicrobial	antimicrobial	NOUN
ct-9997	2	52	to	to	PART
ct-9997	2	53	treat	treat	VERB
ct-9997	2	54	bacterial	bacterial	ADJ
ct-9997	2	55	infections	infection	NOUN
ct-9997	2	56	in	in	ADP
ct-9997	2	57	pregnant	pregnant	ADJ
ct-9997	2	58	mares	mare	NOUN
ct-9997	2	59	if	if	SCONJ
ct-9997	2	60	proven	prove	VERB
ct-9997	2	61	safe	safe	ADJ
ct-9997	2	62	.	.	PUNCT
ct-9997	3	1	previous	previous	ADJ
ct-9997	3	2	work	work	NOUN
ct-9997	3	3	demonstrated	demonstrate	VERB
ct-9997	3	4	that	that	SCONJ
ct-9997	3	5	enrofloxacin	enrofloxacin	PROPN
ct-9997	3	6	crosses	cross	VERB
ct-9997	3	7	the	the	DET
ct-9997	3	8	equine	equine	NOUN
ct-9997	3	9	placenta	placenta	NOUN
ct-9997	3	10	and	and	CCONJ
ct-9997	3	11	reaches	reach	VERB
ct-9997	3	12	therapeutic	therapeutic	ADJ
ct-9997	3	13	concentrations	concentration	NOUN
ct-9997	3	14	in	in	ADP
ct-9997	3	15	the	the	DET
ct-9997	3	16	fetal	fetal	ADJ
ct-9997	3	17	fluids	fluid	NOUN
ct-9997	3	18	without	without	ADP
ct-9997	3	19	apparent	apparent	ADJ
ct-9997	3	20	affects	affect	NOUN
ct-9997	3	21	on	on	ADP
ct-9997	3	22	the	the	DET
ct-9997	3	23	fetus	fetus	NOUN
ct-9997	3	24	,	,	PUNCT
ct-9997	3	25	and	and	CCONJ
ct-9997	3	26	that	that	SCONJ
ct-9997	3	27	ciprofloxacin	ciprofloxacin	NOUN
ct-9997	3	28	,	,	PUNCT
ct-9997	3	29	an	an	DET
ct-9997	3	30	active	active	ADJ
ct-9997	3	31	metabolite	metabolite	NOUN
ct-9997	3	32	of	of	ADP
ct-9997	3	33	enrofloxacin	enrofloxacin	PROPN
ct-9997	3	34	,	,	PUNCT
ct-9997	3	35	accumulates	accumulate	VERB
ct-9997	3	36	in	in	ADP
ct-9997	3	37	the	the	DET
ct-9997	3	38	allantoic	allantoic	NOUN
ct-9997	3	39	fluid	fluid	NOUN
ct-9997	3	40	over	over	ADP
ct-9997	3	41	time	time	NOUN
ct-9997	3	42	(	(	PUNCT
ct-9997	3	43	i.e.	i.e.	X
ct-9997	3	44	,	,	PUNCT
ct-9997	3	45	up	up	ADP
ct-9997	3	46	to	to	PART
ct-9997	3	47	1,000	1,000	NUM
ct-9997	3	48	ng	ng	PROPN
ct-9997	3	49	/	/	SYM
ct-9997	3	50	ml	ml	NOUN
ct-9997	3	51	)	)	PUNCT
ct-9997	3	52	.	.	PUNCT
ct-9997	4	1	however	however	ADV
ct-9997	4	2	,	,	PUNCT
ct-9997	4	3	it	it	PRON
ct-9997	4	4	is	be	AUX
ct-9997	4	5	unknown	unknown	ADJ
ct-9997	4	6	if	if	SCONJ
ct-9997	4	7	in	in	ADP
ct-9997	4	8	utero	utero	ADJ
ct-9997	4	9	exposure	exposure	NOUN
ct-9997	4	10	to	to	ADP
ct-9997	4	11	enrofloxacin	enrofloxacin	PROPN
ct-9997	4	12	and	and	CCONJ
ct-9997	4	13	ciprofloxacin	ciprofloxacin	PROPN
ct-9997	4	14	affect	affect	VERB
ct-9997	4	15	cartilage	cartilage	NOUN
ct-9997	4	16	development	development	NOUN
ct-9997	4	17	in	in	ADP
ct-9997	4	18	the	the	DET
ct-9997	4	19	weight	weight	NOUN
ct-9997	4	20	-	-	PUNCT
ct-9997	4	21	bearing	bear	VERB
ct-9997	4	22	foal	foal	NOUN
ct-9997	4	23	.	.	PUNCT
ct-9997	5	1	we	we	PRON
ct-9997	5	2	hypothesized	hypothesize	VERB
ct-9997	5	3	that	that	SCONJ
ct-9997	5	4	enrofloxacin	enrofloxacin	PROPN
ct-9997	5	5	administration	administration	NOUN
ct-9997	5	6	to	to	ADP
ct-9997	5	7	late	late	ADJ
ct-9997	5	8	-	-	PUNCT
ct-9997	5	9	term	term	NOUN
ct-9997	5	10	pregnant	pregnant	ADJ
ct-9997	5	11	mares	mare	NOUN
ct-9997	5	12	would	would	AUX
ct-9997	5	13	not	not	PART
ct-9997	5	14	produce	produce	VERB
ct-9997	5	15	cartilaginous	cartilaginous	ADJ
ct-9997	5	16	lesions	lesion	NOUN
ct-9997	5	17	or	or	CCONJ
ct-9997	5	18	tendonopathies	tendonopathie	NOUN
ct-9997	5	19	in	in	ADP
ct-9997	5	20	the	the	DET
ct-9997	5	21	resulting	result	VERB
ct-9997	5	22	foal	foal	NOUN
ct-9997	5	23	.	.	PUNCT
ct-9997	6	1	the	the	DET
ct-9997	6	2	objectives	objective	NOUN
ct-9997	6	3	of	of	ADP
ct-9997	6	4	this	this	DET
ct-9997	6	5	study	study	NOUN
ct-9997	6	6	were	be	AUX
ct-9997	6	7	to	to	PART
ct-9997	6	8	determine	determine	VERB
ct-9997	6	9	:	:	PUNCT
ct-9997	6	10	(	(	PUNCT
ct-9997	6	11	i	i	NOUN
ct-9997	6	12	)	)	PUNCT
ct-9997	6	13	if	if	SCONJ
ct-9997	6	14	in	in	ADP
ct-9997	6	15	utero	utero	ADJ
ct-9997	6	16	exposure	exposure	NOUN
ct-9997	6	17	to	to	ADP
ct-9997	6	18	enrofloxacin	enrofloxacin	PROPN
ct-9997	6	19	and	and	CCONJ
ct-9997	6	20	ciprofloxacin	ciprofloxacin	PROPN
ct-9997	6	21	resulted	result	VERB
ct-9997	6	22	in	in	ADP
ct-9997	6	23	clinical	clinical	ADJ
ct-9997	6	24	lameness	lameness	NOUN
ct-9997	6	25	or	or	CCONJ
ct-9997	6	26	lesions	lesion	NOUN
ct-9997	6	27	in	in	ADP
ct-9997	6	28	articular	articular	ADJ
ct-9997	6	29	cartilage	cartilage	NOUN
ct-9997	6	30	or	or	CCONJ
ct-9997	6	31	tendons	tendon	NOUN
ct-9997	6	32	of	of	ADP
ct-9997	6	33	the	the	DET
ct-9997	6	34	foal	foal	NOUN
ct-9997	6	35	,	,	PUNCT
ct-9997	6	36	and	and	CCONJ
ct-9997	6	37	(	(	PUNCT
ct-9997	6	38	ii	ii	NOUN
ct-9997	6	39	)	)	PUNCT
ct-9997	6	40	if	if	SCONJ
ct-9997	6	41	in	in	ADP
ct-9997	6	42	utero	utero	ADJ
ct-9997	6	43	exposure	exposure	NOUN
ct-9997	6	44	resulted	result	VERB
ct-9997	6	45	in	in	ADP
ct-9997	6	46	decreased	decrease	VERB
ct-9997	6	47	tensile	tensile	NOUN
ct-9997	6	48	strength	strength	NOUN
ct-9997	6	49	or	or	CCONJ
ct-9997	6	50	cartilage	cartilage	NOUN
ct-9997	6	51	thickness	thickness	NOUN
ct-9997	6	52	in	in	ADP
ct-9997	6	53	the	the	DET
ct-9997	6	54	resulting	result	VERB
ct-9997	6	55	foals	foal	NOUN
ct-9997	6	56	.	.	PUNCT
ct-9997	7	1	clinically	clinically	ADV
ct-9997	7	2	healthy	healthy	ADJ
ct-9997	7	3	mares	mare	NOUN
ct-9997	7	4	(	(	PUNCT
ct-9997	7	5	7	7	NUM
ct-9997	7	6	-	-	SYM
ct-9997	7	7	23	23	NUM
ct-9997	7	8	years	year	NOUN
ct-9997	7	9	old	old	ADJ
ct-9997	7	10	)	)	PUNCT
ct-9997	7	11	were	be	AUX
ct-9997	7	12	enrolled	enrol	VERB
ct-9997	7	13	in	in	ADP
ct-9997	7	14	the	the	DET
ct-9997	7	15	study	study	NOUN
ct-9997	7	16	at	at	ADP
ct-9997	7	17	280	280	NUM
ct-9997	7	18	days	day	NOUN
ct-9997	7	19	gestation	gestation	NOUN
ct-9997	7	20	,	,	PUNCT
ct-9997	7	21	and	and	CCONJ
ct-9997	7	22	were	be	AUX
ct-9997	7	23	assigned	assign	VERB
ct-9997	7	24	to	to	ADP
ct-9997	7	25	:	:	PUNCT
ct-9997	7	26	1	1	NUM
ct-9997	7	27	)	)	PUNCT
ct-9997	7	28	control	control	NOUN
ct-9997	7	29	(	(	PUNCT
ct-9997	7	30	n=5	n=5	PROPN
ct-9997	7	31	)	)	PUNCT
ct-9997	7	32	,	,	PUNCT
ct-9997	7	33	2	2	X
ct-9997	7	34	)	)	PUNCT
ct-9997	7	35	therapeutic	therapeutic	ADJ
ct-9997	7	36	dose	dose	NOUN
ct-9997	7	37	of	of	ADP
ct-9997	7	38	enrofloxacin	enrofloxacin	PROPN
ct-9997	7	39	(	(	PUNCT
ct-9997	7	40	n=6	n=6	NOUN
ct-9997	7	41	,	,	PUNCT
ct-9997	7	42	7.5mg	7.5mg	NUM
ct-9997	7	43	/	/	SYM
ct-9997	7	44	kg	kg	PROPN
ct-9997	7	45	po	po	NOUN
ct-9997	7	46	)	)	PUNCT
ct-9997	7	47	,	,	PUNCT
ct-9997	7	48	or	or	CCONJ
ct-9997	7	49	3	3	X
ct-9997	7	50	)	)	PUNCT
ct-9997	7	51	double	double	ADJ
ct-9997	7	52	therapeutic	therapeutic	ADJ
ct-9997	7	53	dose	dose	NOUN
ct-9997	7	54	enrofloxacin	enrofloxacin	PROPN
ct-9997	7	55	(	(	PUNCT
ct-9997	7	56	n=6	n=6	NOUN
ct-9997	7	57	,	,	PUNCT
ct-9997	7	58	15	15	NUM
ct-9997	7	59	mg	mg	NUM
ct-9997	7	60	/	/	SYM
ct-9997	7	61	kg	kg	PROPN
ct-9997	7	62	po	po	NOUN
ct-9997	7	63	)	)	PUNCT
ct-9997	7	64	.	.	PUNCT
ct-9997	8	1	enrofloxacin	enrofloxacin	PROPN
ct-9997	8	2	was	be	AUX
ct-9997	8	3	administrated	administrate	VERB
ct-9997	8	4	once	once	ADV
ct-9997	8	5	a	a	DET
ct-9997	8	6	day	day	NOUN
ct-9997	8	7	for	for	ADP
ct-9997	8	8	14	14	NUM
ct-9997	8	9	days	day	NOUN
ct-9997	8	10	,	,	PUNCT
ct-9997	8	11	starting	start	VERB
ct-9997	8	12	280	280	NUM
ct-9997	8	13	days	day	NOUN
ct-9997	8	14	gestation	gestation	NOUN
ct-9997	8	15	.	.	PUNCT
ct-9997	9	1	maternal	maternal	ADJ
ct-9997	9	2	plasma	plasma	NOUN
ct-9997	9	3	samples	sample	NOUN
ct-9997	9	4	were	be	AUX
ct-9997	9	5	collected	collect	VERB
ct-9997	9	6	daily	daily	ADV
ct-9997	9	7	and	and	CCONJ
ct-9997	9	8	plasma	plasma	NOUN
ct-9997	9	9	preserved	preserve	VERB
ct-9997	9	10	at	at	ADP
ct-9997	9	11	-80oc	-80oc	PROPN
ct-9997	9	12	.	.	PUNCT
ct-9997	10	1	transabdominal	transabdominal	ADJ
ct-9997	10	2	ultrasound	ultrasound	NOUN
ct-9997	10	3	guided	guide	VERB
ct-9997	10	4	fetal	fetal	ADJ
ct-9997	10	5	fluid	fluid	NOUN
ct-9997	10	6	sampling	sampling	NOUN
ct-9997	10	7	was	be	AUX
ct-9997	10	8	performed	perform	VERB
ct-9997	10	9	in	in	ADP
ct-9997	10	10	a	a	DET
ct-9997	10	11	subset	subset	NOUN
ct-9997	10	12	of	of	ADP
ct-9997	10	13	mares	mare	NOUN
ct-9997	10	14	(	(	PUNCT
ct-9997	10	15	n=4	n=4	NOUN
ct-9997	10	16	)	)	PUNCT
ct-9997	10	17	at	at	ADP
ct-9997	10	18	330335d	330335d	NUM
ct-9997	10	19	gestation	gestation	NOUN
ct-9997	10	20	,	,	PUNCT
ct-9997	10	21	and	and	CCONJ
ct-9997	10	22	fetal	fetal	ADJ
ct-9997	10	23	fluids	fluid	NOUN
ct-9997	10	24	were	be	AUX
ct-9997	10	25	collected	collect	VERB
ct-9997	10	26	for	for	ADP
ct-9997	10	27	enrofloxacin	enrofloxacin	PROPN
ct-9997	10	28	and	and	CCONJ
ct-9997	10	29	ciprofloxacin	ciprofloxacin	NOUN
ct-9997	10	30	concentrations	concentration	NOUN
ct-9997	10	31	.	.	PUNCT
ct-9997	11	1	mares	mare	NOUN
ct-9997	11	2	were	be	AUX
ct-9997	11	3	allowed	allow	VERB
ct-9997	11	4	to	to	PART
ct-9997	11	5	carry	carry	VERB
ct-9997	11	6	the	the	DET
ct-9997	11	7	foals	foal	NOUN
ct-9997	11	8	to	to	PART
ct-9997	11	9	term	term	VERB
ct-9997	11	10	.	.	PUNCT
ct-9997	12	1	after	after	ADP
ct-9997	12	2	foaling	foaling	NOUN
ct-9997	12	3	,	,	PUNCT
ct-9997	12	4	mares	mare	NOUN
ct-9997	12	5	and	and	CCONJ
ct-9997	12	6	foals	foal	NOUN
ct-9997	12	7	were	be	AUX
ct-9997	12	8	maintained	maintain	VERB
ct-9997	12	9	on	on	ADP
ct-9997	12	10	pasture	pasture	NOUN
ct-9997	12	11	for	for	ADP
ct-9997	12	12	30d	30d	NOUN
ct-9997	12	13	,	,	PUNCT
ct-9997	12	14	until	until	ADP
ct-9997	12	15	foal	foal	NOUN
ct-9997	12	16	euthanasia	euthanasia	NOUN
ct-9997	12	17	.	.	PUNCT
ct-9997	13	1	proximal	proximal	ADJ
ct-9997	13	2	articular	articular	ADJ
ct-9997	13	3	surfaces	surface	NOUN
ct-9997	13	4	of	of	ADP
ct-9997	13	5	foal	foal	NOUN
ct-9997	13	6	long	long	ADJ
ct-9997	13	7	bones	bone	NOUN
ct-9997	13	8	and	and	CCONJ
ct-9997	13	9	fetal	fetal	ADJ
ct-9997	13	10	membranes	membrane	NOUN
ct-9997	13	11	were	be	AUX
ct-9997	13	12	examined	examine	VERB
ct-9997	13	13	macroscopically	macroscopically	ADV
ct-9997	13	14	and	and	CCONJ
ct-9997	13	15	stained	stain	VERB
ct-9997	13	16	with	with	ADP
ct-9997	13	17	he	he	PRON
ct-9997	13	18	for	for	ADP
ct-9997	13	19	histopathological	histopathological	ADJ
ct-9997	13	20	evaluations	evaluation	NOUN
ct-9997	13	21	.	.	PUNCT
ct-9997	14	1	tissues	tissue	NOUN
ct-9997	14	2	were	be	AUX
ct-9997	14	3	graded	grade	VERB
ct-9997	14	4	for	for	ADP
ct-9997	14	5	structural	structural	ADJ
ct-9997	14	6	,	,	PUNCT
ct-9997	14	7	cellular	cellular	ADJ
ct-9997	14	8	,	,	PUNCT
ct-9997	14	9	and	and	CCONJ
ct-9997	14	10	extracellular	extracellular	ADJ
ct-9997	14	11	changes	change	NOUN
ct-9997	14	12	.	.	PUNCT
ct-9997	15	1	tensile	tensile	NOUN
ct-9997	15	2	testing	testing	NOUN
ct-9997	15	3	was	be	AUX
ct-9997	15	4	conducted	conduct	VERB
ct-9997	15	5	on	on	ADP
ct-9997	15	6	superficial	superficial	ADJ
ct-9997	15	7	flexor	flexor	ADJ
ct-9997	15	8	tendons	tendon	NOUN
ct-9997	15	9	by	by	ADP
ct-9997	15	10	loading	load	VERB
ct-9997	15	11	until	until	ADP
ct-9997	15	12	failure	failure	NOUN
ct-9997	15	13	(	(	PUNCT
ct-9997	15	14	instron	instron	PROPN
ct-9997	15	15	8511	8511	NUM
ct-9997	15	16	,	,	PUNCT
ct-9997	15	17	norwood	norwood	PROPN
ct-9997	15	18	,	,	PUNCT
ct-9997	15	19	ma	ma	PROPN
ct-9997	15	20	)	)	PUNCT
ct-9997	15	21	.	.	PUNCT
ct-9997	16	1	histomorphometric	histomorphometric	ADJ
ct-9997	16	2	and	and	CCONJ
ct-9997	16	3	extracellular	extracellular	ADJ
ct-9997	16	4	matrix	matrix	NOUN
ct-9997	16	5	analyses	analysis	NOUN
ct-9997	16	6	were	be	AUX
ct-9997	16	7	evaluated	evaluate	VERB
ct-9997	16	8	using	use	VERB
ct-9997	16	9	a	a	DET
ct-9997	16	10	non	non	ADJ
ct-9997	16	11	-	-	ADJ
ct-9997	16	12	parametric	parametric	ADJ
ct-9997	16	13	kruskal	kruskal	PROPN
ct-9997	16	14	-	-	PUNCT
ct-9997	16	15	wallis	wallis	PROPN
ct-9997	16	16	one	one	NUM
ct-9997	16	17	-	-	PUNCT
ct-9997	16	18	way	way	NOUN
ct-9997	16	19	analysis	analysis	NOUN
ct-9997	16	20	of	of	ADP
ct-9997	16	21	variance	variance	NOUN
ct-9997	16	22	.	.	PUNCT
ct-9997	17	1	enrofloxacin	enrofloxacin	PROPN
ct-9997	17	2	and	and	CCONJ
ct-9997	17	3	ciprofloxacin	ciprofloxacin	NOUN
ct-9997	17	4	concentrations	concentration	NOUN
ct-9997	17	5	were	be	AUX
ct-9997	17	6	measured	measure	VERB
ct-9997	17	7	by	by	ADP
ct-9997	17	8	lc	lc	PROPN
ct-9997	17	9	-	-	PUNCT
ct-9997	17	10	ms	ms	PROPN
ct-9997	17	11	/	/	SYM
ct-9997	17	12	ms	ms	PROPN
ct-9997	17	13	.	.	PROPN
ct-9997	17	14	tensile	tensile	PROPN
ct-9997	17	15	data	datum	NOUN
ct-9997	17	16	were	be	AUX
ct-9997	17	17	analyzed	analyze	VERB
ct-9997	17	18	using	use	VERB
ct-9997	17	19	anova	anova	PROPN
ct-9997	17	20	with	with	ADP
ct-9997	17	21	repeated	repeat	VERB
ct-9997	17	22	measures	measure	NOUN
ct-9997	17	23	and	and	CCONJ
ct-9997	17	24	tukey	tukey	NOUN
ct-9997	17	25	post	post	ADJ
ct-9997	17	26	-	-	ADJ
ct-9997	17	27	hoc	hoc	ADJ
ct-9997	17	28	test	test	NOUN
ct-9997	17	29	in	in	ADP
ct-9997	17	30	r	r	NOUN
ct-9997	17	31	version	version	NOUN
ct-9997	17	32	3.2.2	3.2.2	NUM
ct-9997	17	33	(	(	PUNCT
ct-9997	17	34	https://www.rproject.org/	https://www.rproject.org/	NOUN
ct-9997	17	35	)	)	PUNCT
ct-9997	17	36	.	.	PUNCT
ct-9997	18	1	significance	significance	NOUN
ct-9997	18	2	was	be	AUX
ct-9997	18	3	set	set	VERB
ct-9997	18	4	at	at	ADP
ct-9997	18	5	p<0.05	p<0.05	PROPN
ct-9997	18	6	.	.	PUNCT
ct-9997	19	1	peak	peak	NOUN
ct-9997	19	2	plasma	plasma	NOUN
ct-9997	19	3	concentrations	concentration	NOUN
ct-9997	19	4	were	be	AUX
ct-9997	19	5	1040	1040	NUM
ct-9997	19	6	±	±	NUM
ct-9997	19	7	228	228	NUM
ct-9997	19	8	ng	ng	PROPN
ct-9997	19	9	/	/	SYM
ct-9997	19	10	ml	ml	PROPN
ct-9997	19	11	(	(	PUNCT
ct-9997	19	12	enrofloxacin	enrofloxacin	PROPN
ct-9997	19	13	)	)	PUNCT
ct-9997	19	14	and	and	CCONJ
ct-9997	19	15	210	210	NUM
ct-9997	19	16	±	±	NUM
ct-9997	19	17	25	25	NUM
ct-9997	19	18	ng	ng	PROPN
ct-9997	19	19	/	/	SYM
ct-9997	19	20	ml	ml	PROPN
ct-9997	19	21	(	(	PUNCT
ct-9997	19	22	ciprofloxacin	ciprofloxacin	PROPN
ct-9997	19	23	)	)	PUNCT
ct-9997	19	24	for	for	ADP
ct-9997	19	25	the	the	DET
ct-9997	19	26	7.5	7.5	NUM
ct-9997	19	27	mg	mg	PROPN
ct-9997	19	28	/	/	SYM
ct-9997	19	29	kg	kg	PROPN
ct-9997	19	30	group	group	NOUN
ct-9997	19	31	and	and	CCONJ
ct-9997	19	32	1638	1638	NUM
ct-9997	19	33	±	±	NUM
ct-9997	19	34	246	246	NUM
ct-9997	19	35	ng	ng	PROPN
ct-9997	19	36	/	/	SYM
ct-9997	19	37	ml	ml	PROPN
ct-9997	19	38	(	(	PUNCT
ct-9997	19	39	enrofloxacin	enrofloxacin	PROPN
ct-9997	19	40	)	)	PUNCT
ct-9997	19	41	and	and	CCONJ
ct-9997	19	42	327	327	NUM
ct-9997	19	43	±	±	NUM
ct-9997	19	44	21	21	NUM
ct-9997	19	45	ng	ng	PROPN
ct-9997	19	46	/	/	SYM
ct-9997	19	47	ml	ml	PROPN
ct-9997	19	48	(	(	PUNCT
ct-9997	19	49	ciprofloxacin	ciprofloxacin	PROPN
ct-9997	19	50	)	)	PUNCT
ct-9997	19	51	for	for	ADP
ct-9997	19	52	the	the	DET
ct-9997	19	53	15	15	NUM
ct-9997	19	54	mg	mg	PROPN
ct-9997	19	55	/	/	SYM
ct-9997	19	56	kg	kg	PROPN
ct-9997	19	57	group	group	NOUN
ct-9997	19	58	on	on	ADP
ct-9997	19	59	day	day	NOUN
ct-9997	19	60	1	1	NUM
ct-9997	19	61	.	.	PUNCT
ct-9997	20	1	both	both	CCONJ
ct-9997	20	2	enrofloxacin	enrofloxacin	PROPN
ct-9997	20	3	and	and	CCONJ
ct-9997	20	4	ciprofloxacin	ciprofloxacin	PROPN
ct-9997	20	5	were	be	AUX
ct-9997	20	6	still	still	ADV
ct-9997	20	7	detectable	detectable	ADJ
ct-9997	20	8	in	in	ADP
ct-9997	20	9	the	the	DET
ct-9997	20	10	amniotic	amniotic	ADJ
ct-9997	20	11	(	(	PUNCT
ct-9997	20	12	7.4	7.4	NUM
ct-9997	20	13	±4.7	±4.7	NOUN
ct-9997	20	14	,	,	PUNCT
ct-9997	20	15	15.3	15.3	NUM
ct-9997	20	16	±12.4	±12.4	NUM
ct-9997	20	17	ng	ng	PROPN
ct-9997	20	18	/	/	SYM
ct-9997	20	19	ml	ml	NOUN
ct-9997	20	20	)	)	PUNCT
ct-9997	20	21	and	and	CCONJ
ct-9997	20	22	allantoic	allantoic	ADJ
ct-9997	20	23	(	(	PUNCT
ct-9997	20	24	11.2	11.2	NUM
ct-9997	20	25	±1.0	±1.0	PROPN
ct-9997	20	26	,	,	PUNCT
ct-9997	20	27	148.3	148.3	NUM
ct-9997	20	28	±	±	NUM
ct-9997	20	29	61.1	61.1	NUM
ct-9997	20	30	ng	ng	PROPN
ct-9997	20	31	/	/	SYM
ct-9997	20	32	ml	ml	NOUN
ct-9997	20	33	)	)	PUNCT
ct-9997	20	34	fluids	fluid	NOUN
ct-9997	20	35	thirty	thirty	NUM
ct-9997	20	36	to	to	PART
ct-9997	20	37	forty	forty	NUM
ct-9997	20	38	days	day	NOUN
ct-9997	20	39	after	after	ADP
ct-9997	20	40	administration	administration	NOUN
ct-9997	20	41	of	of	ADP
ct-9997	20	42	the	the	DET
ct-9997	20	43	last	last	ADJ
ct-9997	20	44	dose	dose	NOUN
ct-9997	20	45	.	.	PUNCT
ct-9997	21	1	no	no	DET
ct-9997	21	2	differences	difference	NOUN
ct-9997	21	3	were	be	AUX
ct-9997	21	4	seen	see	VERB
ct-9997	21	5	in	in	ADP
ct-9997	21	6	macroscopic	macroscopic	ADJ
ct-9997	21	7	,	,	PUNCT
ct-9997	21	8	cytological	cytological	ADJ
ct-9997	21	9	,	,	PUNCT
ct-9997	21	10	or	or	CCONJ
ct-9997	21	11	extracellular	extracellular	ADJ
ct-9997	21	12	matrix	matrix	NOUN
ct-9997	21	13	lesions	lesion	NOUN
ct-9997	21	14	in	in	ADP
ct-9997	21	15	the	the	DET
ct-9997	21	16	cartilage	cartilage	NOUN
ct-9997	21	17	of	of	ADP
ct-9997	21	18	foals	foal	NOUN
ct-9997	21	19	from	from	ADP
ct-9997	21	20	control	control	NOUN
ct-9997	21	21	or	or	CCONJ
ct-9997	21	22	treated	treat	VERB
ct-9997	21	23	groups	group	NOUN
ct-9997	21	24	.	.	PUNCT
ct-9997	22	1	no	no	DET
ct-9997	22	2	differences	difference	NOUN
ct-9997	22	3	in	in	ADP
ct-9997	22	4	tendon	tendon	NOUN
ct-9997	22	5	yield	yield	NOUN
ct-9997	22	6	stress	stress	NOUN
ct-9997	22	7	were	be	AUX
ct-9997	22	8	detected	detect	VERB
ct-9997	22	9	between	between	ADP
ct-9997	22	10	the	the	DET
ct-9997	22	11	control	control	NOUN
ct-9997	22	12	(	(	PUNCT
ct-9997	22	13	7.6±	7.6±	PROPN
ct-9997	22	14	1.0	1.0	NUM
ct-9997	22	15	mpa	mpa	NOUN
ct-9997	22	16	)	)	PUNCT
ct-9997	22	17	,	,	PUNCT
ct-9997	22	18	7.5mg	7.5mg	NUM
ct-9997	22	19	/	/	SYM
ct-9997	22	20	kg	kg	PROPN
ct-9997	22	21	(	(	PUNCT
ct-9997	22	22	8.6	8.6	NUM
ct-9997	22	23	±	±	NUM
ct-9997	22	24	1.5	1.5	NUM
ct-9997	22	25	mpa	mpa	NOUN
ct-9997	22	26	)	)	PUNCT
ct-9997	22	27	and	and	CCONJ
ct-9997	22	28	15	15	NUM
ct-9997	22	29	mg	mg	NUM
ct-9997	22	30	/	/	SYM
ct-9997	22	31	kg	kg	PROPN
ct-9997	22	32	(	(	PUNCT
ct-9997	22	33	9.2	9.2	NUM
ct-9997	22	34	±	±	NUM
ct-9997	22	35	1.9	1.9	NUM
ct-9997	22	36	mpa	mpa	PROPN
ct-9997	22	37	)	)	PUNCT
ct-9997	22	38	groups	group	NOUN
ct-9997	22	39	.	.	PUNCT
ct-9997	23	1	these	these	DET
ct-9997	23	2	findings	finding	NOUN
ct-9997	23	3	suggest	suggest	VERB
ct-9997	23	4	that	that	SCONJ
ct-9997	23	5	enrofloxacin	enrofloxacin	PROPN
ct-9997	23	6	administration	administration	NOUN
ct-9997	23	7	to	to	ADP
ct-9997	23	8	the	the	DET
ct-9997	23	9	late	late	ADJ
ct-9997	23	10	pregnant	pregnant	ADJ
ct-9997	23	11	mare	mare	NOUN
ct-9997	23	12	reaches	reach	VERB
ct-9997	23	13	therapeutic	therapeutic	ADJ
ct-9997	23	14	drug	drug	NOUN
ct-9997	23	15	concentrations	concentration	NOUN
ct-9997	23	16	in	in	ADP
ct-9997	23	17	the	the	DET
ct-9997	23	18	fetus	fetus	NOUN
ct-9997	23	19	and	and	CCONJ
ct-9997	23	20	fetal	fetal	ADJ
ct-9997	23	21	fluids	fluid	NOUN
ct-9997	23	22	without	without	ADP
ct-9997	23	23	detrimental	detrimental	ADJ
ct-9997	23	24	effects	effect	NOUN
ct-9997	23	25	on	on	ADP
ct-9997	23	26	the	the	DET
ct-9997	23	27	cartilage	cartilage	NOUN
ct-9997	23	28	and	and	CCONJ
ct-9997	23	29	tendons	tendon	NOUN
ct-9997	23	30	of	of	ADP
ct-9997	23	31	the	the	DET
ct-9997	23	32	resulting	result	VERB
ct-9997	23	33	foal	foal	NOUN
ct-9997	23	34	.	.	PUNCT
ct-9997	24	1	additionally	additionally	ADV
ct-9997	24	2	,	,	PUNCT
ct-9997	24	3	ciprofloxacin	ciprofloxacin	NOUN
ct-9997	24	4	concentrations	concentration	NOUN
ct-9997	24	5	in	in	ADP
ct-9997	24	6	the	the	DET
ct-9997	24	7	allantoic	allantoic	NOUN
ct-9997	24	8	fluid	fluid	NOUN
ct-9997	24	9	may	may	AUX
ct-9997	24	10	remain	remain	VERB
ct-9997	24	11	elevated	elevated	ADJ
ct-9997	24	12	for	for	ADP
ct-9997	24	13	many	many	ADJ
ct-9997	24	14	days	day	NOUN
ct-9997	24	15	after	after	ADP
ct-9997	24	16	administration	administration	NOUN
ct-9997	24	17	of	of	ADP
ct-9997	24	18	last	last	ADJ
ct-9997	24	19	enrofloxacin	enrofloxacin	PROPN
ct-9997	24	20	dose	dose	PROPN
ct-9997	24	21	.	.	PUNCT
ct-9997	25	1	this	this	PRON
ct-9997	25	2	suggests	suggest	VERB
ct-9997	25	3	that	that	SCONJ
ct-9997	25	4	enrofloxacin	enrofloxacin	PROPN
ct-9997	25	5	may	may	AUX
ct-9997	25	6	be	be	AUX
ct-9997	25	7	a	a	DET
ct-9997	25	8	useful	useful	ADJ
ct-9997	25	9	antibiotic	antibiotic	ADJ
ct-9997	25	10	option	option	NOUN
ct-9997	25	11	for	for	ADP
ct-9997	25	12	late	late	ADJ
ct-9997	25	13	pregnant	pregnant	ADJ
ct-9997	25	14	mares	mare	NOUN
ct-9997	25	15	suffering	suffer	VERB
ct-9997	25	16	severe	severe	ADJ
ct-9997	25	17	bacterial	bacterial	ADJ
ct-9997	25	18	infections	infection	NOUN
ct-9997	25	19	.	.	PUNCT
ct-9997	26	1	keywords	keyword	NOUN
ct-9997	26	2	:	:	PUNCT
ct-9997	26	3	fluoroquinolone	fluoroquinolone	NOUN
ct-9997	26	4	,	,	PUNCT
ct-9997	26	5	equine	equine	NOUN
ct-9997	26	6	,	,	PUNCT
ct-9997	26	7	toxicity	toxicity	NOUN
ct-9997	26	8	,	,	PUNCT
ct-9997	26	9	foal	foal	NOUN
ct-9997	26	10	,	,	PUNCT
ct-9997	26	11	pregnancy	pregnancy	NOUN
ct-9997	26	12	clinical	clinical	ADJ
ct-9997	26	13	theriogenology	theriogenology	NOUN
ct-9997	26	14	•	•	NOUN
ct-9997	26	15	volume	volume	NOUN
ct-9997	26	16	10	10	NUM
ct-9997	26	17	,	,	PUNCT
ct-9997	26	18	number	number	NOUN
ct-9997	26	19	3	3	NUM
ct-9997	26	20	•	•	NUM
ct-9997	26	21	september	september	PROPN
ct-9997	26	22	2018309	2018309	NUM